Skip to content

Early Detection of Cardiac Damage by Two-Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy

Early Detection of Cardiac Damage by Two-Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04443400
Enrollment
100
Registered
2020-06-23
Start date
2020-01-01
Completion date
2021-12-31
Last updated
2020-06-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Radiation Therapy

Brief summary

The purpose of this study is to detecte and predict early subclinical cardiac damage induced by thoracic radiation therapy based on two-dimensional speckle tracking echocardiography combined with multiple circulating biomarkers.

Detailed description

This is a monocentric prospective cohort study in which 100 patients treated for malignant tumors and with cardiac radiation exposure will be included.All patient will be followed for 12 months after radiotherapy. Echocardiography, 2D STE parameters and circulating biomarkers will be collected.

Interventions

None listed

Sponsors

Peking University Third Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* with malignant tumors * will receive radiotherapy * with cardiac exposure during the radiotherapy process * could receive regular follow-up for 12 months * written informed consent

Exclusion criteria

* satisfactory echocardiographic images could not be obtained * moderate or severe valvular disease * cardiomyopathy * congenital heart disease * refractory hypertension * coronary artery disease\* * heart failure * arrhythmia requiring intervention * pericarditis * acute myocarditis * participating in other clinical studies of drug intervention * severe liver and kidney dysfunction * autoimmune disease * pulmonary hypertension coronary artery disease: at least 50% stenosis besed on previous coronary angiography or CTA, or with a history of percutaneous coronary stent implantation. \*: with LVEF\<50%, unstable angina,or acute myocardial infarction within 3 months.

Design outcomes

Primary

MeasureTime frameDescription
Early Detection of Cardiac Damage by Two-Dimensional Speckle Tracking Echocardiography After Thoracic Radiation Therapy2020-2021To detecte early subclinical cardiac damage induced by thoracic radiation therapy, based on two-dimensional speckle tracking echocardiography combined with multiple circulating biomarkers

Countries

China

Contacts

Primary ContactDan Zhu, M.D.
andrea_zhu@163.com+8613810103532
Backup ContactTingcui Li
tingcui2019@163.com+8618801236290

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026